Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Live birth after 6 years of oocyte vitrification in a survivor with breast cance (2014)

  • Authors:
  • USP affiliated authors: SERAFINI, PAULO CESAR - FM
  • USP Schools: FM
  • DOI: 10.1007/s10815-014-0314-0
  • Subjects: CRIOPRESERVAÇÃO; FERTILIDADE (PRESERVAÇÃO); NEOPLASIAS MAMÁRIAS; OÓCITOS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s10815-014-0314-0 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: green
    Informações sobre o Citescore
  • Título: Journal of Assisted Reproduction and Genetics

    ISSN: 1058-0468

    Citescore - 2017: 2.49

    SJR - 2017: 1.179

    SNIP - 2017: 0.951


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2646270-10BCSEP 492 2014
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MOTTA, Eduardo Leme Alves da; BONAVITA, Monique; ALEGRETTI, José Roberto; CHEHIN, Maurício; SERAFINI, Paulo. Live birth after 6 years of oocyte vitrification in a survivor with breast cance. Journal of Assisted Reproduction and Genetics, New York, v. 31, n. 10, p. 1397-1400, 2014. Disponível em: < https://link.springer.com/content/pdf/10.1007%2Fs10815-014-0314-0.pdf > DOI: 10.1007/s10815-014-0314-0.
    • APA

      Motta, E. L. A. da, Bonavita, M., Alegretti, J. R., Chehin, M., & Serafini, P. (2014). Live birth after 6 years of oocyte vitrification in a survivor with breast cance. Journal of Assisted Reproduction and Genetics, 31( 10), 1397-1400. doi:10.1007/s10815-014-0314-0
    • NLM

      Motta ELA da, Bonavita M, Alegretti JR, Chehin M, Serafini P. Live birth after 6 years of oocyte vitrification in a survivor with breast cance [Internet]. Journal of Assisted Reproduction and Genetics. 2014 ; 31( 10): 1397-1400.Available from: https://link.springer.com/content/pdf/10.1007%2Fs10815-014-0314-0.pdf
    • Vancouver

      Motta ELA da, Bonavita M, Alegretti JR, Chehin M, Serafini P. Live birth after 6 years of oocyte vitrification in a survivor with breast cance [Internet]. Journal of Assisted Reproduction and Genetics. 2014 ; 31( 10): 1397-1400.Available from: https://link.springer.com/content/pdf/10.1007%2Fs10815-014-0314-0.pdf

    Referências citadas na obra
    Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–48.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
    Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril. 2012;98:1363–9.
    Cobo A, Domingo J, Perez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2008;10:268–73.
    Smith GD, Motta EE, Serafini P. Theoretical and experimental basis of oocyte vitrification. Reprod Biomed Online. 2011;23:298–306.
    Vajta G, Kuwayama M. Improving cryopreservation systems. Theriogenology. 2006;65:236–44.
    Martinez-Burgos M, Herrero L, Megias D, Salvanes R, Montoya MC, Cobo AC, et al. Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage. Fertil Steril. 2011;95:374–7.
    Rodriguez-Wallberg KA, Oktay K. Fertility preservation in women with breast cancer. Clin Obstet Gynecol. 2010;53:753–62.
    Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31:2500–10.
    ASRM PCo. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37–43.
    Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, et al. Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod. 2010;25:66–73.
    Ubaldi F, Anniballo R, Romano S, Baroni E, Albricci L, Colamaria S, et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod. 2010;25:1199–205.
    Garcia-Velasco JA, Domingo J, Cobo A, Martinez M, Carmona L, Pellicer A. Five years’ experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril. 2013;99:1994–9.
    Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769–76.
    Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril. 2010;93:391–6.
    Parmegiani L, Garello C, Granella F, Guidetti D, Bernardi S, Cognigni GE, et al. Long-term cryostorage does not adversely affect the outcome of oocyte thawing cycles. Reprod Biomed Online. 2009;19:374–9.
    Cobo A, Garcia-Velasco JA, Domingo J, Remohi J, Pellicer A. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? Fertil Steril. 2013;99:1485–95.
    Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology. 2007;67:73–80.